Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 15 studies | 28% ± 10% | |
peripheral blood | 14 studies | 31% ± 8% | |
kidney | 8 studies | 24% ± 4% | |
eye | 8 studies | 28% ± 13% | |
brain | 7 studies | 37% ± 11% | |
intestine | 6 studies | 24% ± 10% | |
liver | 5 studies | 30% ± 17% | |
placenta | 4 studies | 26% ± 13% | |
bone marrow | 4 studies | 20% ± 5% | |
uterus | 4 studies | 28% ± 12% | |
breast | 4 studies | 22% ± 4% | |
pancreas | 3 studies | 55% ± 23% | |
lymph node | 3 studies | 27% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 5432.66 | 2642 / 2642 | 100% | 119.10 | 705 / 705 |
esophagus | 100% | 3621.75 | 1445 / 1445 | 100% | 84.52 | 183 / 183 |
lung | 100% | 4056.69 | 578 / 578 | 100% | 101.74 | 1155 / 1155 |
ovary | 100% | 3015.86 | 180 / 180 | 100% | 88.02 | 430 / 430 |
uterus | 100% | 3587.94 | 170 / 170 | 100% | 77.50 | 459 / 459 |
bladder | 100% | 3439.14 | 21 / 21 | 100% | 75.71 | 503 / 504 |
kidney | 100% | 3559.08 | 89 / 89 | 100% | 74.08 | 899 / 901 |
breast | 100% | 3560.27 | 459 / 459 | 100% | 105.87 | 1115 / 1118 |
thymus | 100% | 4141.02 | 653 / 653 | 100% | 96.55 | 603 / 605 |
stomach | 100% | 3182.49 | 359 / 359 | 100% | 69.09 | 285 / 286 |
intestine | 100% | 3677.83 | 966 / 966 | 100% | 67.15 | 525 / 527 |
pancreas | 100% | 2427.35 | 328 / 328 | 99% | 67.10 | 177 / 178 |
prostate | 100% | 3675.87 | 244 / 245 | 100% | 102.23 | 501 / 502 |
liver | 100% | 2969.98 | 226 / 226 | 99% | 42.93 | 401 / 406 |
adrenal gland | 100% | 6530.16 | 258 / 258 | 99% | 74.81 | 227 / 230 |
skin | 100% | 3251.51 | 1803 / 1809 | 94% | 57.34 | 442 / 472 |
adipose | 100% | 3719.46 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 107.97 | 29 / 29 |
spleen | 100% | 4262.41 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 82.56 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 33.67 | 1 / 1 |
blood vessel | 100% | 4018.26 | 1333 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 2545.56 | 800 / 803 | 0% | 0 | 0 / 0 |
heart | 98% | 3033.83 | 843 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 97% | 5328.27 | 901 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 49% | 12.57 | 39 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0060124 | Biological process | positive regulation of growth hormone secretion |
GO_0045454 | Biological process | cell redox homeostasis |
GO_0007204 | Biological process | positive regulation of cytosolic calcium ion concentration |
GO_0098869 | Biological process | cellular oxidant detoxification |
GO_0001514 | Biological process | selenocysteine incorporation |
GO_0031016 | Biological process | pancreas development |
GO_0009749 | Biological process | response to glucose |
GO_0042593 | Biological process | glucose homeostasis |
GO_0035773 | Biological process | insulin secretion involved in cellular response to glucose stimulus |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0008430 | Molecular function | selenium binding |
GO_0004791 | Molecular function | thioredoxin-disulfide reductase (NADPH) activity |
Gene name | SELENOT |
Protein name | Selenoprotein T Thioredoxin reductase-like selenoprotein T (SelT) (EC 1.8.1.9) |
Synonyms | SELT hCG_20913 UNQ150/PRO176 |
Description | FUNCTION: Selenoprotein with thioredoxin reductase-like oxidoreductase activity (By similarity). Protects dopaminergic neurons against oxidative stress and cell death . Involved in ADCYAP1/PACAP-induced calcium mobilization and neuroendocrine secretion (By similarity). Plays a role in fibroblast anchorage and redox regulation (By similarity). In gastric smooth muscle, modulates the contraction processes through the regulation of calcium release and MYLK activation (By similarity). In pancreatic islets, involved in the control of glucose homeostasis, contributes to prolonged ADCYAP1/PACAP-induced insulin secretion (By similarity). . |
Accessions | ENST00000480740.5 P62341 ENST00000492132.1 ENST00000471696.6 ENST00000485923.1 ENST00000477889.5 F8WBD0 F6U0C2 |